Print
Share
RSS
Donate
Because the safe use of the CredibleMeds® lists of medications requires that the user have the most up-to-date lists of drugs, we are informing you of these changes to the QTdrugs.org lists:
1. Addition of Necitumumab (anti-cancer monoclonal antibody) and Ribociclib (anti-cancer, kinase inhibitor) to the Possible Risk (PR) List.
2. Because Foscarnet (anti-viral) has been marketed without any confirmation of earlier reports that it might prolong QT, it has been removed from the Possible Risk list.
A reminder: You can download your FREE CredibleMeds SmartPhone App by clicking any of the following options:
 |
 |
 |
The Apps are synced to the CredibleMeds drugs lists and are therefore always an up-to-date resource for you to search for drugs of interest. We seek your feedback for ways the Apps might be improved to better serve your needs.
Thank you for your support of CredibleMeds.org